img

Global Human Oral Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Human Oral Vaccine Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Human Oral Vaccine market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Human Oral Vaccine market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Human Oral Vaccine in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other

Market Snapshot, By Application
Public
Private

Main Market Players Analyzed in this report, including
Valneva
Vabiotech
Tiantan Biological
Shanghai United Cell
Serum Institute
Sanofi
PaxVax
Panacea Biotec Ltd
Merck
Lanzhou Institute
Halfkin Bio-Pharmaceuticals
GSK
EuBiologics
Bio-Med
Bibcol

The study objectives of this report are
To study and analyze the global Human Oral Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Human Oral Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Human Oral Vaccine manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Oral Vaccine market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Human Oral Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Human Oral Vaccine are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Human Oral Vaccine Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Human Oral Vaccine Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Human Oral Vaccine Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Human Oral Vaccine

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Human Oral Vaccine Sales Channel and Distributors Analysis
3.3.1 Human Oral Vaccine Sales Channel
3.3.2 Human Oral Vaccine Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Public
3.4.2 Major Buyers in Private
3.5 Human Oral Vaccine Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Human Oral Vaccine Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Cholera Vaccine
4.1.3 Oral Polio Vaccine
4.1.4 Other
4.2 Global Human Oral Vaccine Sales by Type 2016-2021
4.3 Global Human Oral Vaccine Revenue by Type 2016-2021
4.4 Global Human Oral Vaccine Price by Type 2016-2021

5 Market Segment: by Application
5.1 Human Oral Vaccine Type Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Human Oral Vaccine Sales by Application 2016-2021
5.3 Global Human Oral Vaccine Revenue by Application 2016-2021
5.4 Global Human Oral Vaccine Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Human Oral Vaccine Market by Region
6.1.1 Global Human Oral Vaccine Sales by Regions
6.1.2 Global Human Oral Vaccine Revenue by Regions
6.2 North America Human Oral Vaccine Market 2016-2021
6.3 Europe Human Oral Vaccine Market 2016-2021
6.4 Asia Pacific Human Oral Vaccine Market 2016-2021
6.5 South America Human Oral Vaccine Market 2016-2021
6.6 Middle East and Africa Human Oral Vaccine Market 2016-2021

7 North America
7.1 North America Human Oral Vaccine Market by Country 2016-2021
7.1.1 North America Human Oral Vaccine Sales by Country
7.1.2 North America Human Oral Vaccine Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Human Oral Vaccine Market by Country 2016-2021
8.1.1 Europe Human Oral Vaccine Sales by Country
8.1.2 Europe Human Oral Vaccine Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Human Oral Vaccine Market by Country 2016-2021
9.1.1 Asia Pacific Human Oral Vaccine Sales by Country
9.1.2 Asia Pacific Human Oral Vaccine Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Human Oral Vaccine Market by Country 2016-2021
10.1.1 South America Human Oral Vaccine Sales by Country
10.1.2 South America Human Oral Vaccine Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Human Oral Vaccine Market by Country 2016-2021
11.1.1 Middle East and Africa Human Oral Vaccine Sales by Country
11.1.2 Middle East and Africa Human Oral Vaccine Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Valneva
12.1.1 Valneva Company Information
12.1.2 Valneva Human Oral Vaccine Product Portfolio, Specification and Application
12.1.3 Valneva Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Valneva Key Development
12.2 Vabiotech
12.2.1 Vabiotech Company Information
12.2.2 Vabiotech Human Oral Vaccine Product Portfolio, Specification and Application
12.2.3 Vabiotech Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Vabiotech Key Development
12.3 Tiantan Biological
12.3.1 Tiantan Biological Company Information
12.3.2 Tiantan Biological Human Oral Vaccine Product Portfolio, Specification and Application
12.3.3 Tiantan Biological Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Tiantan Biological Key Development
12.4 Shanghai United Cell
12.4.1 Shanghai United Cell Company Information
12.4.2 Shanghai United Cell Human Oral Vaccine Product Portfolio, Specification and Application
12.4.3 Shanghai United Cell Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Shanghai United Cell Key Development
12.5 Serum Institute
12.5.1 Serum Institute Company Information
12.5.2 Serum Institute Human Oral Vaccine Product Portfolio, Specification and Application
12.5.3 Serum Institute Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Serum Institute Key Development
12.6 Sanofi
12.6.1 Sanofi Company Information
12.6.2 Sanofi Human Oral Vaccine Product Portfolio, Specification and Application
12.6.3 Sanofi Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Sanofi Key Development
12.7 PaxVax
12.7.1 PaxVax Company Information
12.7.2 PaxVax Human Oral Vaccine Product Portfolio, Specification and Application
12.7.3 PaxVax Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Sanofi Key Development
12.9 Merck
12.9.1 Merck Company Information
12.9.2 Merck Human Oral Vaccine Product Portfolio, Specification and Application
12.9.3 Merck Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Merck Key Development
12.8 Panacea Biotec Ltd
12.8.1 Panacea Biotec Ltd Company Information
12.8.2 Panacea Biotec Ltd Human Oral Vaccine Product Portfolio, Specification and Application
12.8.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Panacea Biotec Ltd Key Development
12.11 Halfkin Bio-Pharmaceuticals
12.11.1 Halfkin Bio-Pharmaceuticals Company Information
12.11.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolio, Specification and Application
12.11.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Halfkin Bio-Pharmaceuticals Key Development
12.12 GSK
12.12.1 GSK Company Information
12.12.2 GSK Human Oral Vaccine Product Portfolio, Specification and Application
12.12.3 GSK Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 GSK Key Development
12.13 EuBiologics
12.13.1 EuBiologics Company Information
12.13.2 EuBiologics Human Oral Vaccine Product Portfolio, Specification and Application
12.13.3 EuBiologics Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 EuBiologics Key Development
12.14 Bio-Med
12.14.1 Bio-Med Company Information
12.14.2 Bio-Med Human Oral Vaccine Product Portfolio, Specification and Application
12.14.3 Bio-Med Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Bio-Med Key Development
12.15 Bibcol
12.15.1 Bibcol Company Information
12.15.2 Bibcol Human Oral Vaccine Product Portfolio, Specification and Application
12.15.3 Bibcol Human Oral Vaccine Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Bibcol Key Development

13 Global Human Oral Vaccine Market Forecast by Region by Type and by Application
13.1 Global Human Oral Vaccine Sales, Revenue Forecast 2022-2027
13.2 Global Human Oral Vaccine Forecast by Regions
13.2.1 Global Human Oral Vaccine Sales Forecast by Region 2022-2027
13.2.2 Global Human Oral Vaccine Revenue Forecast by Region 2022-2027
13.3 Global Human Oral Vaccine Forecast by Type
13.3.1 Global Human Oral Vaccine Sales Forecast by Type 2022-2027
13.3.2 Global Human Oral Vaccine Revenue Forecast by Type 2022-2027
13.3.3 Global Human Oral Vaccine Price Forecast by Type 2022-2027
13.4 Global Human Oral Vaccine Forecast by Application
13.4.1 Global Human Oral Vaccine Sales Forecast by Application 2022-2027
13.4.2 Global Human Oral Vaccine Revenue Forecast by Application 2022-2027
13.4.3 Global Human Oral Vaccine Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer